The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 6,801–6,900 of 31,469
Johnson, R., Dludla, P. V., Muller, C. J. F., Huisamen, B., Essop, M. F., & Louw, J. (2017) · Molecules · doi:10.3390/molecules22020219 · Cited by 54
Body mass index is associated with type 2 diabetes mellitus in Chinese elderly
Zhao, Q., Laukkanen, J. A., Li, Q., & Li, G. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s130014 · Cited by 53
Lefere, S., de Velde, F. V., Devisscher, L., Bekaert, M., Raevens, S., Verhelst, X., Nieuwenhove, Y. V., Praet, M. M., Hoorens, A., Steenkiste, C. V., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.102 · Cited by 53
Bugianesi, E., Bizzarri, C., Rosso, C., Mosca, A., Panera, N., Veraldi, S., Dotta, A., Giannone, G., Raponi, M., Cappa, M., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.140 · Cited by 53
Uemura, H., Katsuura‐Kamano, S., Yamaguchi, M., Bahari, T., Ishizu, M., Fujioka, M., & Arisawa, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178672 · Cited by 53
Yang, Q., Qi, M., Tong, R., Wang, D., Ding, L., Li, Z., Huang, C., Wang, Z., & Yang, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071393 · Cited by 56
Metabolic markers during pregnancy and their association with maternal and newborn weight status
Perichart‐Perera, O., Muñoz‐Manrique, C., Reyes-López, A., Tolentino‐Dolores, M., y Sosa, S. E., & Ramírez-González, M. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180874 · Cited by 56
Peri‐implant parameters and C‐reactive protein levels among patients with different obesity levels
Vohra, F., Alkhudhairy, F., Kheraif, A. A. A., Akram, Z., & Javed, F. (2017) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12556 · Cited by 56
Yadav, R., Hama, S., Liu, Y., Siahmansur, T. J., Schofield, J. D., Syed, A. A., France, M. W., Pemberton, P. W., Adam, S., Ho, J. H., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01512 · Cited by 54
Mameli, C., Krakauer, N. Y., Krakauer, J. C., Bosetti, A., Ferrari, C. M., Moiana, N., Schneider, L. A., Borsani, B., Genoni, T., & Zuccotti, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190426 · Cited by 56
Long, M. T., Pedley, A., Massaro, J. M., Hoffmann, U., Ma, J., Loomba, R. S., Chung, R. T., & Benjamin, E. J. (2018) · Liver International · doi:10.1111/liv.13709 · Cited by 54
de la Rosa, I. A., Escudero‐Contreras, A., Rodríguez‐Cuenca, S., Ruiz-Ponce, M., Jiménez, Y., Ruiz‐Limón, P., Pérez‐Sánchez, C., Ábalos‐Aguilera, M. C., Cecchi, I., Ortega, R., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12743 · Cited by 55
Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study
Köninger, A., Mathan, A., Mach, P., Frank, M., Schmidt, B., Schleußner, E., Kimmig, R., Gellhaus, A., & Dieplinger, H. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0338-x · Cited by 54
Jepson, C., Hsu, J. Y., Fischer, M. J., Kusek, J. W., Lash, J. P., Ricardo, A. C., Schelling, J. R., Feldman, H. I., Appel, L. J., Feldman, H. I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.017 · Cited by 53
Loo, C. H., Tan, W. C., Tang, J. J., et al. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14210 · Cited by 53
Acute Effect of Resistant Starch on Food Intake, Appetite and Satiety in Overweight/Obese Males
Al-Mana, N. M., & Robertson, M. D. (2018) · Nutrients · doi:10.3390/nu10121993 · Cited by 56
Bradley, D. P., Blaszczak, A. M., Yin, Z., Liu, J., Joseph, J. J., Wright, V. P., Anandani, K., NEEDLEMAN, B. J., Noria, S. F., Renton, D., et al. (2019) · Diabetes Care · doi:10.2337/dc18-0870 · Cited by 53
Jang, J., Moon, S., Cho, S., Cho, K. H., & Oh, C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37834-7 · Cited by 54
Cheng, K., Song, Z., Zhang, H., Li, S., Wang, C., Zhang, L., & Wang, T. Z. (2019) · Medical Molecular Morphology · doi:10.1007/s00795-019-00216-7 · Cited by 53
Lemay, V., Caru, M., Samoilenko, M., Drouin, S., Alos, N., Lefebvre, G., Levy, E. H., Lippé, S., Marcil, V., Sultan, S., et al. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001426 · Cited by 55
Lewandowski, K. C., Skowrońska‐Jóźwiak, E., Łukasiak, K., Gałuszko, K., Dukowicz, A., Cedro, M., & Lewiñski, A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.82672 · Cited by 55
Wu, E., Zhang, T., Tan, C., Peng, C., Chisti, Y., Wang, Q., & Gong, J. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02044-y · Cited by 51
Diesel Exhaust Induces Mitochondrial Dysfunction, Hyperlipidemia, and Liver Steatosis
Yin, F., Gupta, R., Vergnes, L., Driscoll, W. S., Ricks, J. L., Ramanathan, G., Stewart, J. A., Shih, D. M., Faull, K. F., Beaven, S. W., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312736 · Cited by 54
Hussein, J., Attia, M. F., El‐Bana, M. A., El‐Daly, S. M., Mohamed, N. R., El-Khayat, Z., & El‐Naggar, M. E. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.201 · Cited by 53
Effectiveness of Aerobic Exercise Programs for Health Promotion in Metabolic Syndrome
Morales‐Palomo, F., Ramírez-Jiménez, M., ORTEGA, J. F., & Mora‐Rodríguez, R. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001983 · Cited by 57
Toshimitsu, T., Gotou, A., Sashihara, T., Hachimura, S., Shioya, N., Suzuki, S., & Asami, Y. (2020) · Nutrients · doi:10.3390/nu12020374 · Cited by 54
Choi, E. Y., Park, S. E., Lee, S. C., Koh, H. J., Kim, S. S., Byeon, S. H., & Kim, M. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.3.4 · Cited by 53
Kazemi, M., Jarrett, B. Y., Vanden Brink, H., Lin, A. W., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2020) · Nutrients · doi:10.3390/nu12071953 · Cited by 53
Zhao, M., Zhou, X., Yuan, C., Li, R., Ma, Y., & Tang, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-73176-z · Cited by 53
Suárez‐Cuenca, J. A., la Peña‐Sosa, G. D., la Vega-Moreno, K. D., Banderas-Lares, D. Z., Salamanca-García, M., Martínez-Hernández, J. E., Vera‐Gómez, E., Hernández‐Patricio, A., Zamora-Alemán, C. R., Domínguez-Pérez, G. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81289-2 · Cited by 61
Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women
Kim, H. C. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i34.5314 · Cited by 54
Dwyer, T., Blizzard, L., Venn, A., Stankovich, J. M., Ponsonby, A., & Morley, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802111 · Cited by 52
Domingo, P., Gallego-Escuredo, J. M., Domingo, J. C., Gutiérrez, M. D. M., Mateo, G. M., Fernández, I., Vidal, F., Giralt, M., & Villarroya, F. (2010) · AIDS · doi:10.1097/qad.0b013e3283400088 · Cited by 53
Gender Dimorphism in Skeletal Muscle Leptin Receptors, Serum Leptin and Insulin Sensitivity
Guerra, B., Fuentes, T., Delgado‐Guerra, S., Guadalupe‐Grau, A., Olmedillas, H., Santana, A., Ponce‐González, J. G., Dorado, C., & Calbet, J. A. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003466 · Cited by 55
Kaushik, S. V., Plaisance, E. P., Kim, T., Huang, E. Y., Mahurin, A. J., Grandjean, P. W., & Mathews, S. T. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.967 · Cited by 53
de Luis, D. A., de la Fuente, R. A., Sagrado, M. G., et al. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.03.009 · Cited by 53
van der Vleuten, G. M., Kluijtmans, L. A. J., Hijmans, A., Blom, H. J., Stalenhoef, A. F. H., & Graaf, J. D. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803234 · Cited by 53
Elkind-Hirsch, K. E., Darensbourg, C., Ogden, B. W., Ogden, L. F., & Hindelang, P. (2007) · Contraception · doi:10.1016/j.contraception.2007.08.001 · Cited by 55
Neyestani, T. R., Shariatzade, N., Kalayi, A., Gharavi, A., Khalaji, N., Dadkhah-Piraghaj, M., Zowghi, T., Haidari, H., & Shab‐Bidar, S. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000312666 · Cited by 53
Hoenig, M. E., Thomaseth, K., Brandao, J., Waldron, M. K., & Ferguson, D. C. (2006) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2005.12.004 · Cited by 53
Santos, L. C., Cintra, I. D. P., Fisberg, M., & Martini, L. A. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00848.x · Cited by 53
Cholesterol synthesis prevails over absorption in metabolic syndrome
Gylling, H., Hallikainen, M., Kolehmainen, M., Toppinen, L., Pihlajamäki, J., Mykkänen, H. M., Ågren, J. J., Rauramaa, R., Laakso, M., & Miettinen, T. A. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.012 · Cited by 53
Puchau, B., Zulet, M. Á., de Echávarri, A. G., Navarro-Blasco, Í., & Martínez, J. A. (2008) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2008.48 · Cited by 53
Mitsuyoshi, H., Itoh, Y., Sumida, Y., Minami, M., Yasui, K., Nakashima, T., & Okanoue, T. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00280.x · Cited by 55
Retnakaran, R. R., Hanley, A. J., Connelly, P. W., Harris, S. B., & Zinman, B. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00533.x · Cited by 52
Prevalence of the metabolic syndrome and associated lifestyles in adult males from Oaxaca, Mexico
Ramírez-Vargas, E., Arnaud-Viñas, M. D. R., & Delisle, H. F. (2007) · Salud Pública de México · doi:10.1590/s0036-36342007000200004 · Cited by 53
Yasuda, S., Miyazaki, S., Kanda, M., Goto, Y., Suzuki, M., Harano, Y., & Nonogi, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi876 · Cited by 53
Rao, F., Wessel, J., Wen, G., Zhang, L., Rana, B. K., Kennedy, B. P., Greenwood, T. A., Salem, R. M., Chen, Y., Khandrika, S., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.081679 · Cited by 53
Shahmanesh, M., Das, S., Stolinski, M., Shojaee‐Moradie, F., Jackson, N. C., Jefferson, W., Cramb, R., Nightingale, P., & Umpleby, A. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1273 · Cited by 54
Lim, S. C., Morgenthaler, N. G., Subramaniam, T., Wu, Y. S., Goh, S. K., & Sum, C. F. (2007) · Diabetes Care · doi:10.2337/dc06-1899 · Cited by 54
Lee, G. A., Lo, J. C.-M., Aweeka, F. T., Schwarz, J., Mulligan, K. M., Schambelan, M., & Grünfeld, C. (2006) · Clinical Infectious Diseases · doi:10.1086/505974 · Cited by 52
Horikoshi, M., Hara, K., Ohashi, J., Miyake, K., Tokunaga, K., Ito, C., Kasuga, M., Nagai, R., & Kadowaki, T. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0727 · Cited by 52
Ramos-Romero, S., Hereu, M., Atienza, L., Casas, J., Jáuregui, O., Amézqueta, S., Dasilva, G., Medina, I., Nogués, M. R., Romeu, M., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2017 · Cited by 52
Cho, N. H., Jang, H. C., Park, H. K., & Cho, Y. W. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.06.003 · Cited by 53
Wall, B. T., Dirks, M. L., Snijders, T., Stephens, F. B., Senden, J. M. G., Verscheijden, M.-L., & van Loon, L. J. C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.11.019 · Cited by 52
Bagley, L., Slevin, M., Bradburn, S., Liu, D., Murgatroyd, C., Morrissey, G., Carroll, M., Piasecki, M., Gilmore, W. S., & McPhee, J. S. (2016) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2015-000056 · Cited by 52
Dimitriadis, G., Lambadiari, V., Mitrou, P., Maratou, E., Boutati, E., Panagiotakos, D. B., Economopoulos, T., & Raptis, S. A. (2007) · Diabetes Care · doi:10.2337/dc07-0699 · Cited by 52
Sleep disordered breathing and metabolic syndrome.
Nieto, F. J., Peppard, P. E., & Young, T. B. (2009) · PubMed · Cited by 53
Shea, J. L., French, C. R., Bishop, J., Martin, G., Roebothan, B., Pace, D., Fitzpatrick, D., & Sun, G. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.25970 · Cited by 54
Diniz, M. D. F. H. S., Beleigoli, A. M. R., Schmidt, M. I., et al. (2020) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00072120 · Cited by 52
Sørensen, A. E., van Poppel, M. N. M., Desoyé, G., Damm, P., Simmons, D. S., Jensen, D., Dalgaard, L. T., & The DALI Core Investigator Group (2021) · Cells · doi:10.3390/cells10010170 · Cited by 58
Gunasekar, S. K., Xie, L., Kumar, A., Hong, J., Chheda, P. R., Chen, K., Kern, D. M., My-Ta, C., Maurer, J. M., Heebink, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28435-0 · Cited by 51
Fat Distribution Within the Pancreas According to Diabetes Status and Insulin Traits
Skudder‐Hill, L., Sequeira, I. R., Cho, J., Ko, J., Poppitt, S. D., & Petrov, M. S. (2022) · Diabetes · doi:10.2337/db21-0976 · Cited by 53
Patton, L., Ricolfi, L., Bortolon, M., Gabriele, G., Zolesio, P., Cione, E., & Cannataro, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031599 · Cited by 56
Liang, D., Liu, C., & Wang, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02248-5 · Cited by 53
Tian, S., Lei, Y., Zhao, F., Che, J., Wu, Y.-H., Lei, P., Kang, Y. E., & Shan, Y. (2024) · Food & Function · doi:10.1039/d4fo01059k · Cited by 60
Li, X.-H., Xin, X., Wang, Y., Wu, J.-Z., Jin, Z.-D., Ma, L.-N., Nie, C., Xiao, X., Hu, Y., & Jin, M.-W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122017 · Cited by 52
Kawata, T., Daimon, M., Miyazaki, S., Ichikawa, R., Maruyama, M., Chiang, S.-J., Ito, C., Sato, F., Watada, H., & Daida, H. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0263-7 · Cited by 52
Scherbakov, N., Bauer, M., Sandek, A., Szabo, T. S., Töpper, A., Jankowska, E. A., Springer, J., von Haehling, S., Anker, S. D., Lainščak, M., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.317 · Cited by 52
All-Trans Retinoic Acid Decreases Murine Adipose Retinol Binding Protein 4 Production
Mercader, J., Granados, N., Bonet, M. L., & Palou, A. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000149815 · Cited by 52
Phillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., McManus, R., Herçberg, S., Lairon, D., Planells, R., & Roche, H. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.029 · Cited by 53
Lim, S. K., Kwon, S., Yoon, J. W., Kim, S. Y., Choi, S. H., Park, Y. J., Yoon, H. I., Chang, Y., Lee, J. H., Lee, C., et al. (2010) · Obesity · doi:10.1038/oby.2010.167 · Cited by 53
Sakurai, M., Takamura, T., Ota, T., Ando, H., Akahori, H., Kaji, K., Sasaki, M., Nakanuma, Y., Miura, K., & Kaneko, S. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1948- · Cited by 52
Early onset of obesity induces reproductive deficits in female rats
Schneider, S. C. S., Menezes, E. F., Bonfleur, M. L., Vanzela, E. C., Zacharias, P., Lubaczeuski, C., Franci, C. R., & Sanvitto, G. L. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.12.002 · Cited by 55
Toussirot, É. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00453 · Cited by 53
Howie, G., Sloboda, D. M., Reynolds, C. M., & Vickers, M. H. (2013) · Journal of Nutrition and Metabolism · doi:10.1155/2013/517384 · Cited by 53
The Association between Uric Acid and Chronic Kidney Disease in Korean Men: A 4-Year Follow-up Study
Ryoo, J., Choi, J., Oh, C., & Kim, M. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.6.855 · Cited by 51
Hau, D., Lohsoonthorn, V., Jiamjarasrangsi, W., Lertmaharit, S., & Williams, M. A. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.013 · Cited by 52
Correlates of Serum Resistin in Elderly, Non-Diabetic Patients with Chronic Kidney Disease
Marouga, A., Dalamaga, Μ., Kastania, A., et al. (2013) · Clinical Laboratory · doi:10.7754/clin.lab.2012.121112 · Cited by 52
Lasram, M. M., Dhouib, I. B., Bouzid, K., Jrad-Lamine, A., Annabi, A. B., Belhadjhmida, N., Ahmed, M. B., Fazâa, S. E., Abdelmoula, J., & Gharbi, N. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.08.007 · Cited by 53
Sleepiness as a marker of glucose deregulation in obstructive sleep apnea
Nena, E., Steiropoulos, P., Παπάνας, Ν., Tsara, V., Fitili, C., Froudarakis, Μ. E., Maltezos, E. S., & Bouros, D. E. (2011) · Sleep And Breathing · doi:10.1007/s11325-010-0472-y · Cited by 53
Abnormal Glucose Metabolism and Insulin Sensitivity in Chinese Patients with Gitelman Syndrome
Ren, H., Qin, L., Wang, W., Ma, J., Zhang, W., Shen, P. Y., Shi, H., Li, X., & Chen, N. (2013) · American Journal of Nephrology · doi:10.1159/000346708 · Cited by 51
Vinluan, C. M., Zreikat, H. H., Levy, J. R., & Cheang, K. I. (2011) · Metabolism · doi:10.1016/j.metabol.2011.07.002 · Cited by 54
Glycated haemoglobin as a predictor for metabolic syndrome in non‐diabetic Korean adults
Sung, K., & Rhee, E. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02146.x · Cited by 52
Aicher, B. O., Haser, E. K., Freeman, L. A., Carnie, A., Stonik, J. A., Wang, X., Remaley, A. T., Kato, G. J., & Cannon, R. O. (2012) · Obesity · doi:10.1038/oby.2012.56 · Cited by 52
Díaz-Soto, G., de Luis, D. A., Conde, R., Izaola-Jáuregui, O., Ramos, C., & Romero, E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.01.019 · Cited by 54
Knuiman, M. W., Hung, J., Divitini, M., Davis, T. M. E., & Beilby, J. P. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832955fc · Cited by 52
Beddhu, S., Nigwekar, S. U., Ma, X., & Greene, T. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp057 · Cited by 50
Reeds, D. N., Yarasheski, K. E., Fontana, L., Cade, W. T., Laciny, E., DeMoss, A. J., Patterson, B. W., Powderly, W. G., & Klein, S. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00236.2005 · Cited by 52
Elevated Chemerin Levels in Pakistani Men: An Interrelation with Metabolic Syndrome Phenotypes
Fatima, S. S., Bozaoglu, K., Rehman, R., Alam, F., & Memon, A. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057113 · Cited by 53
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load
Derosa, G., Maffioli, P., Ferrari, I., Fogari, E., D’Angelo, A., Palumbo, I., Randazzo, S., Bianchi, L., & Cicero, A. F. G. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.015 · Cited by 52
Castro, M. C., Francini, F., Schinella, G. R., Caldiz, C. I., Zubiría, M. G., Gagliardino, J. J., & Massa, M. L. (2012) · Clinical Science · doi:10.1042/cs20110665 · Cited by 52
Sankar, P., Bobby, Z., Vickneshwaran, V., Jacob, S. E., & Sridhar, M. G. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.02.001 · Cited by 54
Machado, P. P. A., de Oliveira, B. D., Dock‐Nascimento, D. B., et al. (2013) · Nutrition · doi:10.1016/j.nut.2013.02.003 · Cited by 52
Ormseth, M. J., Ll, S., Fazio, S., Linton, M., Raggi, P., Solus, J. F., Oeser, A. M., Bian, A., Gebretsadik, T. S., Shintani, A., et al. (2012) · Lupus · doi:10.1177/0961203312462756 · Cited by 52
Rosmond, R., Chagnon, M., Bouchard, C., & Björntorp, P. A. (2003) · Hormone Research in Paediatrics · doi:10.1159/000069323 · Cited by 52
Koyasu, M., Ishii, H., Watarai, M., Takemoto, K., Inden, Y., Takeshita, K., Amano, T., Yoshikawa, D., Matsubara, T., & Murohara, T. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.015 · Cited by 52
Impaired left ventricular mechanics in nonalcoholic fatty liver disease
Karabay, C. Y., Kocabay, G., Kalaycı, A., et al. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000008 · Cited by 52
Lobato, N. S., Filgueira, F. P., Akamine, E. H., Davel, A. P., Rossoni, L. V., Tostes, R. C., de Carvalho, M. H. C., & Fortes, Z. B. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.006 · Cited by 53
Abete, I., Parra, D., Crujeiras, A. B., Goyenechea, E., & Martínez, J. A. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00902.x · Cited by 52
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
